Intellectual Property
Intellectual Property » Pharma Regulation & Marketing
The expiry of patents for blockbuster drugs, Federal Government efforts to save on the reimbursement of pharmaceutical costs, ongoing difficulties in getting new product into the pipeline and continuing scrutiny of company practices have put the pharmaceuticals industry under intense pressure.
In such an environment it is vital for the pharmaceutical companies to have lawyers with deep global experience, high levels of technical expertise and a good understanding of pharmaceutical companies’ appetite for risk to achieve as much as possible in a difficult situation.
Our Thinking
Do you have the tactical and strategic edge in litigation?
From time to time you will be faced with a step which is unusual and not generally taken by lawyers. But if followed in the appropriate way it can save the client considerable time and money.
MoreDoing Business In Australia
Australia is an exceptional place in which to do business. Find out how we can help you develop your business in Australia.
Download
Safety first: copyright exemption for generics
The safe and effective use of medicine relies on doctors, pharmacists and other health professionals receiving consistent safety information about each medicine, regardless of its brand.
MoreOur Experts
Our Thinking
Doing Business In Australia
Australia is an exceptional place in which to do business. Find out how we can help you develop your business in Australia.
Safety first: copyright exemption for generics
The safe and effective use of medicine relies on doctors, pharmacists and other health professionals receiving consistent safety information about each medicine, regardless of its brand.
Do you have the tactical and strategic edge in litigation?
From time to time you will be faced with a step which is unusual and not generally taken by lawyers. But if followed in the appropriate way it can save the client considerable time and money.
Corrs in Brief: TGA pursues importer, Court imposes $3.1 millon penalty
7th March 2012 |
Our Experts
Matthew Swinn
Partner Melbourne +61 3 9672 3155